Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA‐149 in epithelial ovarian cancer
Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant cont...
Saved in:
Published in | The journal of obstetrics and gynaecology research Vol. 46; no. 4; pp. 625 - 635 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Kyoto, Japan
John Wiley & Sons Australia, Ltd
01.04.2020
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim
This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC.
Methods
Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected.
Results
Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells.
Conclusion
Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC. |
---|---|
AbstractList | Aim
This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC.
Methods
Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected.
Results
Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells.
Conclusion
Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC. This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ-PVT1 in EOC. Circ-PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR-149, miR-183 and miR-194) expressions were detected in circ-PVT1 overexpression treated CAOV3 cells and circ-PVT1 knock-down treated SKOV3 cells. Furthermore, miR-149 overexpression and miR-149 knock-down plasmids were transfected into circ-PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Circ-PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ-PVT1 knock-down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ-PVT1 overexpression. Besides, circ-PVT1 negatively regulated miR-149 but not miR-183 or miR-194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR-149 knock-down increased cell proliferation but decreased apoptosis in circ-PVT1 knock-down treated SKOV3 cells, while miR-149 overexpression reduced cell proliferation but enhanced apoptosis in circ-PVT1 overexpression treated CAOV3 cells. Circ-PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR-149 in EOC cells, which suggests that circ-PVT1 may serve as a treatment target in EOC. Abstract Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Results Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells. Conclusion Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC. AIMThis study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ-PVT1 in EOC. METHODSCirc-PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR-149, miR-183 and miR-194) expressions were detected in circ-PVT1 overexpression treated CAOV3 cells and circ-PVT1 knock-down treated SKOV3 cells. Furthermore, miR-149 overexpression and miR-149 knock-down plasmids were transfected into circ-PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. RESULTSCirc-PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ-PVT1 knock-down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ-PVT1 overexpression. Besides, circ-PVT1 negatively regulated miR-149 but not miR-183 or miR-194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR-149 knock-down increased cell proliferation but decreased apoptosis in circ-PVT1 knock-down treated SKOV3 cells, while miR-149 overexpression reduced cell proliferation but enhanced apoptosis in circ-PVT1 overexpression treated CAOV3 cells. CONCLUSIONCirc-PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR-149 in EOC cells, which suggests that circ-PVT1 may serve as a treatment target in EOC. |
Author | Gao, Yuqiang Sun, Xiaofeng Luo, Ling |
Author_xml | – sequence: 1 givenname: Xiaofeng surname: Sun fullname: Sun, Xiaofeng organization: Medical School of Hunan University of Chinese Medicine – sequence: 2 givenname: Ling surname: Luo fullname: Luo, Ling organization: The Third Xiangya Hospital of Central South University – sequence: 3 givenname: Yuqiang orcidid: 0000-0001-9092-9865 surname: Gao fullname: Gao, Yuqiang email: gualiao4239609@163.com organization: Zaozhuang Municipal Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32048451$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1uFSEYhompsT-68AYMiRu7mPaDgQMsm5NaNY01prqdMAzMcDIHRpjRdFfvwGv0SuR4qgsT2cDi-R6-N-8xOggxWISeEzgj5ZxvYn9GGFHwCB0RxkQFgq8OyrtmpJIgVofoOOcNABGKyCfosKbAJOPkCH1f-2SWUSf88f0F_vD5lmAbBh2MzdjYccRTiqN3NunZx4DbZcY-DL71c8Z6itMcs894HlJc-gHnKYbehx5vvUmxGH_e_yBMlRFsJz8PdvR6xPGrTl4HbHbfpKfosdNjts8e7hP06fXl7fpNdX1z9XZ9cV0ZxmqoOm6doK3lWilhmFPcSVVTY6w0rXNOG2M6qYEqWndqJbjsiIMOgGoqDUB9gl7tvSXRl8Xmudn6vIuog41LbmjNGeEgxA59-Q-6iUsKZbtCSQ5c1StaqNM9VaLmnKxrpuS3Ot01BJpdL2Wqb373UtgXD8al3druL_mniAKc74FvfrR3_zc1726u9spfVyaasg |
CitedBy_id | crossref_primary_10_1007_s00432_022_04328_z crossref_primary_10_3389_fcell_2022_1044897 crossref_primary_10_3390_cancers12061472 crossref_primary_10_1186_s12935_022_02602_1 crossref_primary_10_3390_cancers14225711 crossref_primary_10_1038_s41420_021_00577_y crossref_primary_10_1007_s13258_020_01023_6 crossref_primary_10_1080_15476286_2020_1789819 crossref_primary_10_1007_s10620_021_06894_7 crossref_primary_10_1186_s12943_022_01514_y crossref_primary_10_1186_s13048_021_00891_0 crossref_primary_10_1038_s41420_022_01192_1 crossref_primary_10_1016_j_gendis_2022_05_037 crossref_primary_10_1186_s13046_021_01964_0 crossref_primary_10_1007_s10528_024_10665_0 crossref_primary_10_15252_embj_2022112408 crossref_primary_10_3892_mmr_2021_12323 crossref_primary_10_1186_s11658_021_00284_7 crossref_primary_10_3389_fonc_2021_762960 crossref_primary_10_1007_s00432_022_04468_2 crossref_primary_10_1016_j_reprotox_2023_108499 crossref_primary_10_1016_j_toxlet_2023_07_008 crossref_primary_10_1016_j_ygeno_2020_06_051 crossref_primary_10_1007_s11010_020_03840_5 crossref_primary_10_1186_s11658_022_00385_x crossref_primary_10_1002_jcla_24009 crossref_primary_10_1016_j_gene_2021_145497 |
Cites_doi | 10.1186/s13059-017-1368-y 10.1016/j.canlet.2016.12.006 10.1016/j.canlet.2011.01.026 10.1016/j.bbrc.2019.03.121 10.7150/jca.31615 10.1007/s00261-019-02175-0 10.1186/s13046-019-1103-5 10.1016/j.clinthera.2018.01.012 10.2217/epi-2017-0142 10.1016/j.biopha.2018.12.007 10.1089/cbr.2018.2641 10.1016/j.biopha.2019.108832 10.7150/ijbs.24360 10.1016/j.biopha.2018.06.112 10.1038/cr.2015.82 10.3233/CBM-190064 10.1016/j.canlet.2015.06.003 10.1016/S0140-6736(18)32552-2 10.1002/ijc.29210 |
ContentType | Journal Article |
Copyright | 2020 Japan Society of Obstetrics and Gynecology 2020 Japan Society of Obstetrics and Gynecology. |
Copyright_xml | – notice: 2020 Japan Society of Obstetrics and Gynecology – notice: 2020 Japan Society of Obstetrics and Gynecology. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TO H94 K9. 7X8 |
DOI | 10.1111/jog.14190 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1447-0756 |
EndPage | 635 |
ExternalDocumentID | 10_1111_jog_14190 32048451 JOG14190 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of Hunan funderid: 2018JJ2290 – fundername: National Natural Science Foundation of China funderid: 81774362; 81303004 – fundername: National Natural Science Foundation of China grantid: 81774362 – fundername: National Natural Science Foundation of Hunan grantid: 2018JJ2290 – fundername: National Natural Science Foundation of China grantid: 81303004 |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TO H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4430-d5ef72be5a997c4f95f8932cce8cbfffacccd8a02923d96758d1f0d002a28c003 |
IEDL.DBID | DR2 |
ISSN | 1341-8076 |
IngestDate | Fri Aug 16 22:18:38 EDT 2024 Thu Oct 10 19:55:41 EDT 2024 Fri Aug 23 01:13:59 EDT 2024 Sat Sep 28 08:25:37 EDT 2024 Sat Aug 24 01:08:52 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | cell apoptosis circular RNA-PVT1 epithelial ovarian cancer cell proliferation microRNA-149 |
Language | English |
License | 2020 Japan Society of Obstetrics and Gynecology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4430-d5ef72be5a997c4f95f8932cce8cbfffacccd8a02923d96758d1f0d002a28c003 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-9092-9865 |
PMID | 32048451 |
PQID | 2385059362 |
PQPubID | 2045132 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2354150770 proquest_journals_2385059362 crossref_primary_10_1111_jog_14190 pubmed_primary_32048451 wiley_primary_10_1111_jog_14190_JOG14190 |
PublicationCentury | 2000 |
PublicationDate | April 2020 |
PublicationDateYYYYMMDD | 2020-04-01 |
PublicationDate_xml | – month: 04 year: 2020 text: April 2020 |
PublicationDecade | 2020 |
PublicationPlace | Kyoto, Japan |
PublicationPlace_xml | – name: Kyoto, Japan – name: Australia – name: Hoboken |
PublicationTitle | The journal of obstetrics and gynaecology research |
PublicationTitleAlternate | J Obstet Gynaecol Res |
PublicationYear | 2020 |
Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
References | 2011; 303 2016; 6 2015; 25 2018; 106 2015; 136 2019; 10 2015; 365 2019; 34 2019; 23 2019; 26 2019 2019; 512 2019; 38 2019; 114 2018; 40 2017; 18 2019; 393 2017; 388 2018; 10 2018; 42 2019; 111 2018; 15 2018; 14 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_23_1 e_1_2_7_11_1 e_1_2_7_22_1 e_1_2_7_10_1 e_1_2_7_21_1 Sun L (e_1_2_7_25_1) 2018; 15 Wang F (e_1_2_7_9_1) 2016; 6 Su Y (e_1_2_7_8_1) 2018; 42 Zhao Y (e_1_2_7_20_1) 2019; 23 Fan B (e_1_2_7_24_1) 2019; 23 |
References_xml | – volume: 14 start-page: 321 year: 2018 end-page: 330 article-title: Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1 publication-title: Int J Biol Sci – volume: 111 start-page: 244 year: 2019 end-page: 250 article-title: Circular RNA PVT1 acts as a competing endogenous RNA for miR‐497 in promoting non‐small cell lung cancer progression publication-title: Biomed Pharmacother – volume: 10 start-page: 723 year: 2018 end-page: 732 article-title: Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia publication-title: Epigenomics – volume: 23 start-page: 1934 year: 2019 end-page: 1946 article-title: MiR‐15a‐3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1 publication-title: Eur Rev Med Pharmacol Sci – volume: 26 start-page: 151 year: 2019 end-page: 161 article-title: Circular RNA ABCB10 correlates with advanced clinicopathological features and unfavorable survival, and promotes cell proliferation while reduces cell apoptosis in epithelial ovarian cancer publication-title: Cancer Biomark – volume: 18 start-page: 237 year: 2017 article-title: The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription‐competent complex publication-title: Genome Biol – volume: 15 start-page: 7328 year: 2018 end-page: 7334 article-title: MicroRNA‐149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X‐linked inhibitor of apoptosis publication-title: Oncol Lett – volume: 512 start-page: 716 year: 2019 end-page: 722 article-title: Circular RNA PVT1 promotes metastasis via miR‐145 sponging in CRC publication-title: Biochem Biophys Res Commun – year: 2019 article-title: Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer publication-title: Abdom Radiol (NY) – volume: 40 start-page: 361 year: 2018 end-page: 371 article-title: Use of targeted therapeutics in epithelial ovarian cancer: A review of current literature and future directions publication-title: Clin Ther – volume: 6 start-page: 1167 year: 2016 end-page: 1176 article-title: Circular RNAs as potential biomarkers for cancer diagnosis and therapy publication-title: Am J Cancer Res – volume: 10 start-page: 3908 year: 2019 end-page: 3913 article-title: circGFRA1 promotes ovarian cancer progression by sponging miR‐449a publication-title: J Cancer – volume: 303 start-page: 73 year: 2011 end-page: 83 article-title: Chemotherapy in epithelial ovarian cancer publication-title: Cancer Lett – volume: 106 start-page: 61 year: 2018 end-page: 67 article-title: Long non‐coding RNA PVT1 promotes cell proliferation and invasion through regulating miR‐133a in ovarian cancer publication-title: Biomed Pharmacother – volume: 34 start-page: 110 year: 2019 end-page: 118 article-title: Upregulation of circular RNA VPS13C‐has‐circ‐001567 promotes ovarian cancer cell proliferation and invasion publication-title: Cancer Biother Radiopharm – volume: 136 start-page: E359 year: 2015 end-page: E386 article-title: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer – volume: 25 start-page: 981 year: 2015 end-page: 984 article-title: Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis publication-title: Cell Res – volume: 388 start-page: 208 year: 2017 end-page: 219 article-title: Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer publication-title: Cancer Lett – volume: 393 start-page: 1240 year: 2019 end-page: 1253 article-title: Epithelial ovarian cancer publication-title: Lancet – volume: 42 start-page: 1786 year: 2018 end-page: 1798 article-title: Circular RNA, a novel marker for cancer determination (review) publication-title: Int J Mol Med – volume: 38 start-page: 110 year: 2019 article-title: HOXD‐AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR‐186‐5p and PIK3R3 publication-title: J Exp Clin Cancer Res – volume: 23 start-page: 5603 year: 2019 end-page: 5610 article-title: Circular RNA circ‐SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6 publication-title: Eur Rev Med Pharmacol Sci – volume: 365 start-page: 141 year: 2015 end-page: 148 article-title: Circular RNA: A new star of noncoding RNAs publication-title: Cancer Lett – volume: 114 year: 2019 article-title: Circ‐CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR‐1236‐3p sponge publication-title: Biomed Pharmacother – ident: e_1_2_7_14_1 doi: 10.1186/s13059-017-1368-y – ident: e_1_2_7_10_1 doi: 10.1016/j.canlet.2016.12.006 – ident: e_1_2_7_6_1 doi: 10.1016/j.canlet.2011.01.026 – ident: e_1_2_7_12_1 doi: 10.1016/j.bbrc.2019.03.121 – ident: e_1_2_7_22_1 doi: 10.7150/jca.31615 – ident: e_1_2_7_3_1 doi: 10.1007/s00261-019-02175-0 – ident: e_1_2_7_23_1 doi: 10.1186/s13046-019-1103-5 – volume: 23 start-page: 1934 year: 2019 ident: e_1_2_7_24_1 article-title: MiR‐15a‐3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1 publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Fan B – volume: 42 start-page: 1786 year: 2018 ident: e_1_2_7_8_1 article-title: Circular RNA, a novel marker for cancer determination (review) publication-title: Int J Mol Med contributor: fullname: Su Y – volume: 15 start-page: 7328 year: 2018 ident: e_1_2_7_25_1 article-title: MicroRNA‐149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X‐linked inhibitor of apoptosis publication-title: Oncol Lett contributor: fullname: Sun L – ident: e_1_2_7_5_1 doi: 10.1016/j.clinthera.2018.01.012 – volume: 6 start-page: 1167 year: 2016 ident: e_1_2_7_9_1 article-title: Circular RNAs as potential biomarkers for cancer diagnosis and therapy publication-title: Am J Cancer Res contributor: fullname: Wang F – ident: e_1_2_7_11_1 doi: 10.2217/epi-2017-0142 – ident: e_1_2_7_13_1 doi: 10.1016/j.biopha.2018.12.007 – ident: e_1_2_7_18_1 doi: 10.1089/cbr.2018.2641 – ident: e_1_2_7_19_1 doi: 10.1016/j.biopha.2019.108832 – ident: e_1_2_7_15_1 doi: 10.7150/ijbs.24360 – ident: e_1_2_7_16_1 doi: 10.1016/j.biopha.2018.06.112 – ident: e_1_2_7_17_1 doi: 10.1038/cr.2015.82 – ident: e_1_2_7_21_1 doi: 10.3233/CBM-190064 – volume: 23 start-page: 5603 year: 2019 ident: e_1_2_7_20_1 article-title: Circular RNA circ‐SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6 publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Zhao Y – ident: e_1_2_7_7_1 doi: 10.1016/j.canlet.2015.06.003 – ident: e_1_2_7_2_1 doi: 10.1016/S0140-6736(18)32552-2 – ident: e_1_2_7_4_1 doi: 10.1002/ijc.29210 |
SSID | ssj0017918 |
Score | 2.4131641 |
Snippet | Aim
This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more... This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more... Abstract Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and... AimThis study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more... AIMThis study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 625 |
SubjectTerms | Apoptosis Apoptosis - genetics Carcinoma, Ovarian Epithelial - genetics cell apoptosis Cell growth Cell Line, Tumor Cell proliferation Cell Proliferation - genetics Cell surface Circular RNA circular RNA‐PVT1 Epithelial cells epithelial ovarian cancer Female Humans MicroRNAs MicroRNAs - genetics microRNA‐149 miRNA Ovarian cancer Ovarian Neoplasms - genetics Plasmids RNA, Circular - genetics RNA, Long Noncoding - genetics |
Title | Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA‐149 in epithelial ovarian cancer |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.14190 https://www.ncbi.nlm.nih.gov/pubmed/32048451 https://www.proquest.com/docview/2385059362 https://search.proquest.com/docview/2354150770 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9VAFD4hLAwbX_i4imYwLtyU3E6nr7giKBIS0BAwLEyaeUKDts1trwtX-g_4jfwSz5k-IhAT465JOzNt55wz32m_-Q7Aa7ST1PBIBEakeSAy4QIVuzzIJc9TnmWhVp5tcZjsnYj90_h0Bd6Oe2F6fYjpgxt5ho_X5OBStX86eX2Gbo7rGcbfMEqJzvXuaJKOItVNvw0OozQJ7iaDqpBn8Ywtr69FtwDmdbzqF5zde_BlvNWeZ3KxtezUlv5xQ8XxP5_lPtwdgCjb7i3nAazY6iHcORh-ta_Dr51y4Tmq7Ohwm336fBwyW52TjbSMvvazhur9ONtbEFPLjpXVeanKrmWyqZuubsuWDWWAGBFxqRwS-0YEQOzx6uclZk3YhNmGtoV8RT9g9XfM3GXFNA2zeAQnu--Pd_aCoV5DoIWI5oGJrUu5srHM81QLl8cO0RDX2mZaOeek1tpkcs4RVJqcMhUTurnBmCx5pjG8PIbVqq7sU2DKJXZuMpdGIhLCJgoDujXcogFpJxI1g1fjzBVNL8tRTOlMfVb4lzmDjXFOi8Ez2wIhSuzLGPIZbE6n0afo1cnK1ku6JhYElFPs4klvC9MoESkdizicwRs_o38fvtj_-MEfPPv3S5_DGqeE3lODNmC1WyztC0Q9nXrpzfs3Y9_-eQ |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtRAEC2FIEEu7CQDARrEgYujmXZ7k7hEgTCEZEDRBOWCLPeWWAHbGntyyAn-gG_kS6hqLyIgJMTNkpe2u-tVv2pXvwJ4jnYSae4LT4so8UQsrCcDm3hJxpOIx_FESZdtMQunR2LvODhegZf9XphWH2JYcCNkOH9NAKcF6V9RXp4gznFCuwJXEe4-FW54dTiIR5HuptsIh36aJHfDTlfI5fH0t16ejf6gmJcZq5tydm_Cp_5l20yTs61lI7fUxW86jv_7NbfgRsdF2XZrPLdhxRR34NpB97f9LnzbyRcuTZUdzrbZh4_zCTPFKZlJzWjBn1VU8sea1oiYXDYsL05zmTc1y6qyaso6r1lXCYhRLi5VRGJfKAcQn_jj63cMnPAWZiraGfIZocDKcwzes4IpamZxD452X893pl5XssFTQvhjTwfGRlyaIEuSSAmbBBYJEVfKxEpaazOllI6zMUdeqRMKVvTEjjW65YzHCj3MfVgtysJsAJM2NGMd28gXvhAmlOjTjeYGbUhZEcoRPOuHLq1aZY50iGjKk9R15gg2-0FNO3DWKbKUwFUy5CN4OpxGWFHXZYUpl3RNIIgrR_iI9dYYhlZ8EjsWwWQEL9yQ_r35dO_9G3fw4N8vfQLXp_OD_XT_7ezdQ1jjFN-7TKFNWG0WS_MISVAjHztb_wkzVQKg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcKM-ytIBBHLik2nWcl3qqWpZSYKmqFvWAFMWvNgKSaJPlwKn8g_7G_pLOOA9REBLiFil-xPbM-Btn_A3AS5STSHNfeFpEiSdiYT0Z2MRLMp5EPI4nSrpoi1m4dyz2T4KTJdjq78K0_BDDgRtphrPXpOCVtr8qeXmKao772Q24KUJEvoSIDgfuKKLddPfg0EwT427Y0Qq5MJ6-6vXN6A-EeR2wuh1nugqf-29tA02-bC4aual-_Ebj-J-DuQO3OyTKtlvRuQtLprgHKx-6f-334edOPndBquxwts0OPh1NmCnOSEhqRsf9rKKEP9a0IsTkomF5cZbLvKlZVpVVU9Z5zbo8QIwicSkfEvtGEYDY4uX5BbpNWIWZiu6FfEVFYOV3dN2zginqZv4Ajqevj3b2vC5hg6eE8MeeDoyNuDRBliSREjYJLMIhrpSJlbTWZkopHWdjjqhSJ-Sq6IkdazTKGY8V2peHsFyUhXkETNrQjHVsI1_4QphQokU3mhuUIGVFKEfwol-5tGp5OdLBnylPUzeZI9jo1zTtVLNOEaMELo8hH8Hz4TUqFU1dVphyQWUCQUg5wibWWlkYevGJ6lgEkxG8civ69-7T_Y9v3MPjfy_6DFYOdqfp-7ezd-twi5Nz78KENmC5mS_ME0RAjXzqJP0KMz0BTw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circular+RNA+PVT1+enhances+cell+proliferation+but+inhibits+apoptosis+through+sponging+microRNA-149+in+epithelial+ovarian+cancer&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Sun%2C+Xiaofeng&rft.au=Luo%2C+Ling&rft.au=Gao%2C+Yuqiang&rft.date=2020-04-01&rft.eissn=1447-0756&rft.volume=46&rft.issue=4&rft.spage=625&rft.epage=635&rft_id=info:doi/10.1111%2Fjog.14190&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon |